Literature DB >> 18830062

Distribution frequency of pathogenic bacteria isolated from cutaneus leishmaniasis lesions.

Hengameh Ziaei1, Giti Sadeghian, S H Hejazi.   

Abstract

Cutaneous leishmaniasis (CL) is a parasitic disease characterized by single or multiple ulcerations. Secondary bacterial infections are one of the complications that can increase the tissue destruction and the resulting scar. To better determine the incidence of real secondary bacterial infections in CL, we designed the current study. This was a cross-sectional study performed in Skin Diseases and Leishmaniasis Research Centre, Isfahan, Iran. A total of 1,255 patients with confirmed CL enrolled in the study. Sterile swaps were achieved for ulcer exudates and scraping was used for non-ulcerated lesions. All samples were transferred to tryptic soy broth medium. After 24 hr of incubation at 37 degrees C they were transferred to eosin methylene blue agar (EMB) and blood agar. Laboratory tests were used to determine the species of bacteria. Among 1,255 confirmed CL patients, 274 (21.8%) had positive cultures for secondary bacterial infections. The bacteria isolated from the lesions were Staphylococcus aureus in 190 cases (69.3%), coagulase negative Staphylococcus in 63 cases (23.0%), E. coli in 10 cases (3.6%), Proteus sp. in 6 cases (2.2%), and Klebsiella sp. in 5 cases (1.9%). The results show that the overall incidence of secondary bacterial infections in the lesions of CL was 21.8%, considerably high. The incidence of secondary bacterial infections was significantly higher in ulcerated lesions compared with non-ulcerated lesions.

Entities:  

Mesh:

Year:  2008        PMID: 18830062      PMCID: PMC2553339          DOI: 10.3347/kjp.2008.46.3.191

Source DB:  PubMed          Journal:  Korean J Parasitol        ISSN: 0023-4001            Impact factor:   1.341


  7 in total

1.  Worldwide increasing risk factors for leishmaniasis.

Authors:  P Desjeux
Journal:  Med Microbiol Immunol       Date:  2001-11       Impact factor: 3.402

2.  Studies on the leishmaniases in the Sudan. 2. Clinical and parasitological studies on cutaneous leishmaniasis.

Authors:  S H el-Safi; W Peters; B el-Toam; A el-Kadarow; D A Evans
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Jul-Aug       Impact factor: 2.184

3.  Diffuse cutaneous leishmaniasis in Ethiopia. I. The clinical and histological features of the disease.

Authors:  A D Bryceson
Journal:  Trans R Soc Trop Med Hyg       Date:  1969       Impact factor: 2.184

4.  Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas?

Authors:  M Addy; A Nandy
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

5.  Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major.

Authors:  Abdulrahman A Alrajhi; Elfaki A Ibrahim; Edward B De Vol; Mohammad Khairat; Rajab M Faris; James H Maguire
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

6.  Leishmania major: bacterial contamination of cutaneous lesions in experimental animals.

Authors:  J el-On; R Sneier; E Elias
Journal:  Isr J Med Sci       Date:  1992-12

7.  Detection of pathogenic bacteria in skin lesions of patients with chiclero's ulcer. Reluctant response to antimonial treatment.

Authors:  Angélica Patricia Isaac-Márquez; Claudio Manuel Lezama-Dávila
Journal:  Mem Inst Oswaldo Cruz       Date:  2004-03-09       Impact factor: 2.743

  7 in total
  8 in total

1.  A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasis.

Authors:  Roshan Ramanathan; Kawsar R Talaat; Daniel P Fedorko; Siddhartha Mahanty; Theodore E Nash
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

2.  The relative contribution of co-infection to focal infection risk in children.

Authors:  Joanne Lello; Stefanie Knopp; Khalfan A Mohammed; I Simba Khamis; Jürg Utzinger; Mark E Viney
Journal:  Proc Biol Sci       Date:  2013-01-08       Impact factor: 5.349

3.  Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection.

Authors:  G Sadeghian; H Ziaei; L Shirani Bidabadi; A Zolfaghari Baghbaderani
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

4.  Bacterial contamination in cutaneous leishmaniasis: its effect on the lesions' healing course.

Authors:  Pouran Layegh; Kiarash Ghazvini; Toktam Moghiman; Fatemeh Hadian; Naghmeh Zabolinejad; Fakhrozaman Pezeshkpour
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

5.  In Vitro and In Vivo Control of Secondary Bacterial Infection Caused by Leishmania major.

Authors:  Hany M Yehia; Ebtesam M Al-Olayan; Manal F El-Khadragy; Dina M Metwally
Journal:  Int J Environ Res Public Health       Date:  2017-07-13       Impact factor: 3.390

Review 6.  Cutaneous Manifestations of Human and Murine Leishmaniasis.

Authors:  Breanna M Scorza; Edgar M Carvalho; Mary E Wilson
Journal:  Int J Mol Sci       Date:  2017-06-18       Impact factor: 5.923

7.  Coinfection with Leishmania major and Staphylococcus aureus enhances the pathologic responses to both microbes through a pathway involving IL-17A.

Authors:  Tiffany Y Borbón; Breanna M Scorza; Gwendolyn M Clay; Fellipe Lima Nobre de Queiroz; Alan J Sariol; Jayden L Bowen; Yani Chen; Bayan Zhanbolat; Corey P Parlet; Diogo G Valadares; Suzanne L Cassel; William M Nauseef; Alexander R Horswill; Fayyaz S Sutterwala; Mary E Wilson
Journal:  PLoS Negl Trop Dis       Date:  2019-05-20

8.  The microbiological signature of human cutaneous leishmaniasis lesions exhibits restricted bacterial diversity compared to healthy skin.

Authors:  Vanessa R Salgado; Artur T L de Queiroz; Sabri S Sanabani; Camila I de Oliveira; Edgar M Carvalho; Jackson M L Costa; Manoel Barral-Netto; Aldina Barral
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-04       Impact factor: 2.743

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.